Radius Health's ($RDUS) shares slipped on Tuesday after the company said it was postponing a planned FDA filing for its osteoporosis drug. But CEO Robert Ward ...
MONSEY, N.Y., April 24, 2023 (GLOBE NEWSWIRE) -- After the filing of a preliminary proxy, the law firm of Wohl & Fruchter LLP continues to investigate the fairness of the price of $15.00 per share in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results